Genetic variation in VEGF family genes and breast cancer risk: A report from the shanghai breast cancer genetics study

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 1, 2011, Pages 33-41

  Beeghly Fadiel, Alicia ^a   Shu, Xiao Ou ^a   Lu, Wei ^b   Long, Jirong ^a   Cai, Qiuyin ^a   Xiang, Yong Bing ^c   Zheng, Ying ^b   Zhao, Zhongming ^d   Gu, Kai ^b   Gao, Yu Tang ^c   Zheng, Wei ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Shanghai Center for Disease Control and Prevention   (China)

^c SHANGHAI CANCER INSTITUTE   (China)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ALLELE; ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MULTIGENE FAMILY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; YOUNG ADULT;

EID: 78651429011     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0793     Document Type: Article

References (39)

1. Takahashi H, Shibuya M. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci (Lond) 2005;109:227-41.
2. Roy H, Bhardwaj S, Yla-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett 2006;580:2879-87.
3. Roskoski R Jr. Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit Rev Oncol Hematol 2007;62:179-213.
4. Byrne AM, Bouchier-Hayes DJ, Harmey JH. Angiogenic and cell survival functions ofvascular endothelial growth factor (VEGF). J Cell Mol Med 2005;9:777-94.
5. Kowanetz M, Ferrara N. Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clin Cancer Res 2006;12:5018-22.
6. Breen EC. VEGF in biological control. J Cell Biochem 2007; 102:1358-67.
7. Epstein RJ. VEGF signaling inhibitors: more pro-apoptotic than anti-angiogenic. Cancer Metastasis Rev 2007;26:443-52.
8. Shibuya M. Vascular endothelial growth factor receptor-1 (VEGFR-1/ Flt-1): a dual regulator for angiogenesis. Angiogenesis 2006;9:225-30.
9. Krippl P, Langsenlehner U, Renner W, et al. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 2003;106:468-71.
10. Smith KC, Bateman AC, Fussell HM, Howell WM. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. Eur J Immunogenet 2004;31:167-73.
11. Jin Q, Hemminki K, Enquist K, Lenner P, Grzybowska E, Klaes R, et al. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 2005;11:3647-53.
12. Jacobs EJ, Feigelson HS, Bain EB, Brady KA, Rodriguez C, Stevens VL, et al. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res 2006;8:R22.
13. Kataoka N, Cai Q, Wen W, Shu XO, Jin F, Gao YT, et al. Population- based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women. Cancer Epidemiol Biomarkers Prev 2006;15:1148-52.
14. Balasubramanian SP, Cox A, Cross SS, Higham SE, Brown NJ, Reed MW. Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity. Int J Cancer 2007;121:1009-16. (Pubitemid 47101636)
15. Eroglu A, Ozturk A, Cam R, Akar N. Vascular endothelial growth factor gene 936 C/T polymorphism in breast cancer patients. Med Oncol 2008;25:54-5.
16. Jakubowska A, Gronwald J, Menkiszak J, Gorski B, Huzarski T, Byrski T, et al. The VEGF-936-C>T3'UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women. Cancer Lett 2007;262;71-6.
17. Langsenlehner U, Wolf G, Langsenlehner T, Gerger A, Hofmann G, Clar H, et al. Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "Tumor of Breast Tissue: Incidence, Genetics, and Environmental Risk Factors" study. Breast Cancer Res Treat 2008;109:297-304.
18. Schneider BP, Radovich M, Sledge GW, Robarge JD, Li L, Storniolo AM, et al. Association of polymorphisms of angiogenesis genes with breast cancer. Breast Cancer Res Treat 2008;111:157-63.
19. Forsti A, Jin Q, Altieri A, Johansson R, Wagner K, Enquist K, et al. Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis. Breast Cancer Res Treat 2007;101:83-93.
20. Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB, et al. Genome- wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet 2009;41:324-8.
21. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population- based linkage analyses. Am J Hum Genet 2007;81:559-75.
22. Shahbazi M, Fryer AA, Pravica V, Brogan IJ, Ramsay HM, Hutchinson IV, et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 2002;13:260-4.
23. Salvarani C, Boiardi L, Casali B, Olivieri I, Cantini F, Salvi F, et al. Vascular endothelial growth factor gene polymorphisms in Behcet's disease. J Rheumatol 2004;31:1785-9.
24. Prior SJ, Hagberg JM, Paton CM, Douglass LW, Brown MD, McLenithan JC, et al. DNA sequence variation in the promoter region of the VEGF gene impacts VEGF gene expression and maximal oxygen consumption. Am J Physiol Heart Circ Physiol 2006;290: H1848-55.
25. Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 2003;63:812-6.
26. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger EA. Common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000;37:443-8.
27. Awata T, Inoue K, Kurihara S, et al. A common polymorphism in the 5'- untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002;51:1635-9.
28. Brogan IJ, Khan N, Isaac K, Hutchinson JA, Pravica V, Hutchinson IV. Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 1999;60:1245-9.
29. Yang B, Cross DF, Ollerenshaw M, Millward BA, Demaine AG. Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. J Diabetes Complications 2001;17:1-6.
30. Nakanishi K, Watanabe C. Single nucleotide polymorphisms of vascular endothelial growth factor gene intron 2 are markers for early progression of diabetic retinopathy in Japanese with type 1 diabetes. Clin Chim Acta 2009;402:171-5.
31. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005;438:820-7.
32. Flicek P, Aken BL, Ballester B, Beal K, Bragin E, Brent S, et al. Ensembl's 10th year. Nucleic Acids Res 2010;38:D557-62.
33. Yuan HY, Chiou JJ, Tseng WH, Liu CH, Liu CK, Lin YJ, et al. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 2006;34: W635-41.
34. Blumberg HP, Wang F, Chepenik LG, Kalmar JH, Edmiston E, Duman RS, et al. Influence of vascular endothelial growth factor variation on human hippocampus morphology. Biol Psychiatry 2008;64:901-3.
35. Cao C, Ying T, Fang JJ, Sun SF, Lv D, Chen ZB, et al. Polymorphism of vascular endothelial growth factor -2578C/A with cancer risk: evidence from 11263 subjects. Med Oncol 2010; DOI 10.1007/s12032- 010-9613-1.
36. Gu D, Wang M. VEGF 936C>T polymorphism and breast cancer risk: evidence from 5,729 cases and 5,868 controls. Breast Cancer Res Treat 2011;125:489-93.
37. Xu B, Feng NH, Tong N, Wang ZD, Zhang W, Wu HF, et al. VEGF -460C>T polymorphism and cancer risk: a meta-analysis. Med Oncol 2010;27:1031-6.
38. Xu B, Li JM, Tong N, et al. VEGFA +936C>T polymorphism and cancer risk: a meta-analysis. Cancer Genet Cytogenet 2010;198: 7-14.
39. Yang DS, Park KH, Woo OH, Woo SU, Kim AR, Lee ES, et al. Association of a vascular endothelial growth factor gene 936 C/T polymorphism with breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2010; DOI 10.10.1007/5/0549-10- 1070-1.